Reliability of the Dutch Version of the Matson Evaluation of Drug Side Effects in People With Intellectual Disabilities
This study demonstrated moderate to excellent intrarater and interrater reliabilities for the Dutch version of the MEDS. This confirms its potential as a valuable instrument for clinicians to identify and monitor side effects in people with intellectual disabilities using psychotropic medication. We recommend the use of the Dutch version of the MEDS in both Dutch clinical practice and research for this purpose.
Authors
- Patrick Bindels (ORCID: https://orcid.org/0000-0001-5941-4820)
- Maureen B. G. Wissing (ORCID: https://orcid.org/0000-0003-3371-4547)
- Dederieke A. M. Festen (ORCID: https://orcid.org/0000-0002-7613-0720)
- Maria Louise Dieudonnée Hoekstra‐van Duijn (ORCID: https://orcid.org/0000-0001-5696-6988)
Institutions
- Erasmus MC (NL)
- Department of Health and Aged Care (AU)
- Netherlands Consortium for Healthy Ageing (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Journal of Intellectual Disability Research
- Published
- 2025-05-31
- DOI
- https://doi.org/10.1111/jir.13256
- Primary Topic
- Down syndrome and intellectual disability research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- ZonMw